Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Apex Biotechnology's dividends per share for the
three
months ended in Dec. 2025 was NT$0.00. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$1.20. Its Dividend Payout Ratio for the
three
months ended in Dec. 2025 was 0.00. As of today, Apex Biotechnology's Dividend Yield % is 4.11%.
Good Sign:
Apex Biotechnology Corp stock Dividend Yield % is close to 2-year high.
During the past 12 months, Apex Biotechnology's average Dividends Per Share Growth Rate was 9.10% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -2.60% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 1.40% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was -1.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Apex Biotechnology was 51.20% per year. The lowest was -54.10% per year. And the median was -5.10% per year.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Apex Biotechnology (TPE:1733) Dividends per Share Explanation
1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.
Apex Biotechnology's Dividend Payout Ratio for the quarter that ended in Dec. 2025 is calculated as
During the past 13 years, the highest Dividend Payout Ratio of Apex Biotechnology was 70.03. The lowest was 0.40. And the median was 0.84.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Apex Biotechnology Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
TWD 1.300000
2026-06-09
2026-06-10
2026-07-09
Cash Dividend
annually
TWD:TWD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Apex Biotechnology's Dividend Yield (%) for Today is calculated as
Current Share Price is NT$31.60.
Apex Biotechnology's Dividends per Share for the trailing twelve months (TTM) ended in Today is NT$1.3.
During the past 13 years, the highest Dividend Yield of Apex Biotechnology was 10.92%. The lowest was 0.90%. And the median was 4.22%.
Good Sign:
Apex Biotechnology Corp stock Dividend Yield % is close to 2-year high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apex Biotechnology Dividends per Share Related Terms
Apex Biotechnology Dividends per Share Historical Data
* Premium members only.
The historical data trend for Apex Biotechnology's Dividends per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:1733 vs VRTX, REGN, ALNY: Dividends per Share Comparison
For the Biotechnology subindustry, Apex Biotechnology's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apex Biotechnology Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Apex Biotechnology's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Apex Biotechnology's Dividend Yield % falls into.
Apex Biotechnology (TPE:1733) has a Dividends per Share of NT$1.20 as of Dec. 2025. Dividends per share represents the per-share amount paid as dividends. View historical data on Apex Biotechnology and its competitors.
Is Apex Biotechnology's Dividends per Share too high?
Apex Biotechnology's current Dividends per Share is NT$1.20. Overall, Apex Biotechnology has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Apex Biotechnology's Dividends per Share compare to VRTX and REGN?
Apex Biotechnology's Dividends per Share of NT$1.20 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Biotechnology company?
A good Dividends per Share depends on the Biotechnology industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Apex Biotechnology and its competitors. Apex Biotechnology's current Dividends per Share is NT$1.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apex Biotechnology stock overvalued right now?
Based on GuruFocus' analysis, Apex Biotechnology (TPE:1733) is currently considered Fairly Valued. The stock's GF Value™ is NT$30.02, compared to a current price of NT$31.60 — trading 5.3% above its estimated fair value. The current Dividends per Share is NT$1.20. Apex Biotechnology's overall GF Score™ is 80/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Apex Biotechnology (TPE:1733), the current Dividends per Share is NT$1.20 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Apex Biotechnology (TPE:1733) Overvalued in 2026?
Based on GuruFocus' analysis, Apex Biotechnology stock appears to be overvalued.
The current stock price of NT$31.60 is trading 5.3% above its estimated GF Value™ of NT$30.02.
GuruFocus considers Apex Biotechnology to be Fairly Valued.
Key valuation signals for TPE:1733:
Dividends per Share: NT$1.20
GF Value™: NT$30.02 vs. price of NT$31.60 (5.3% above fair value)
No single metric tells the full story. See the TPE:1733 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Apex Biotechnology Corp is engaged in the research, development, production, manufacturing, and sale of biochemical testing instruments and proprietary test strips, as well as the import and export of products and components related to its core business. Its product offerings include diabetes testing kits, blood uric acid monitoring systems, blood lactate monitoring systems, blood haemoglobin monitoring systems, etc. The company generates maximum revenue from the sale of test strips, and the rest from testing meters, electrodes, and other products. Geographically, it derives maximum revenue from the USA, and the rest from Italy, Austria, Taiwan, China, and other markets.
80GF Score
Get the complete analysis for TPE:1733
Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1733 has been successfully added to your 
